<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2024-4-264-271</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-582</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Синдром сухого глаза, ассоциированный с дисфункцией мейбомиевых желез на фоне применения изотретиноина: клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>Dry eye syndrome associated with meibomian gland dysfunction in the context of isotretinoin use: a clinical case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4138-0495</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселе</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kisele</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Киселе Анастасия Сергеевна, врач-офтальмолог Клинико-диагностического центра на Солянке</p><p>109240,  г. Москва, ул. Солянка, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Anastasia S. Kisele, Ophthalmologist at the Clinical Diagnostic Center on Solyanka </p><p>12 Bldg. 1, Solyanka Str., Moscow, 109240</p></bio><email xlink:type="simple">jatsunchik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-6587-6329</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маслова</surname><given-names>E. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Maslova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маслова Екатерина Владимировна, кандидат медицинских наук, врач-офтальмолог Клинико-диагностического центра на Солянке</p><p>109240,  г. Москва, ул. Солянка, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Ekaterina V. Maslova, Cand. Sci. (Med.), Ophthalmologist at the Clinical  Diagnostic Center on Solyanka</p><p>12 Bldg. 1, Solyanka Str., Moscow, 109240</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-5112-5321</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трубилин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Trubilin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Трубилин Александр Владимирович, кандидат медицинских наук, главный специалист</p><p>109240,  г. Москва, ул. Солянка, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Alexander V. Trubilin, Cand. Sci. (Med.), Chief Specialist</p><p>12 Bldg. 1, Solyanka Str., Moscow, 109240</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-3356-3152</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яворовская</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yavorovskaya</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яворовская Александра Александровна, врач-офтальмолог Клинико-диагностического центра на Солянке</p><p>109240,  г. Москва, ул. Солянка, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Alexandra A. Yavorovskaya, Ophthalmologist at the Clinical Diagnostic Center on Solyanka</p><p>12 Bldg. 1, Solyanka Str., Moscow, 109240</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-8583-7350</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернуха</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernukha</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чернуха Вячеслав Андреевич, врач-офтальмолог Клинико-диагностического центра на Солянке</p><p>109240,  г. Москва, ул. Солянка, д. 12, стр. 1</p></bio><bio xml:lang="en"><p>Vyacheslav A. Chernukha, Ophthalmologist at the Clinical Diagnostic Center on Solyanka</p><p>12 Bldg. 1, Solyanka Str., Moscow, 109240</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">АО «Группа компаний “МЕДСИ”»<country>Россия</country></aff><aff xml:lang="en">“MEDSI” Group of Companies<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2024</year></pub-date><volume>26</volume><issue>4</issue><fpage>264</fpage><lpage>272</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/582">https://www.theeyeglaz.com/jour/article/view/582</self-uri><abstract><p>Актуальность. Акне представляет собой хроническое воспалительное и рецидивирующее заболевание кожи, которое сопровождается значительными эстетическими и психологическими последствиями для пациентов. Препаратом первой линии в терапии акне является изотретиноин, который оказывает системное воздействие на организм, способствуя уменьшению секреции себума и купированию воспалительных процессов. Однако одним из наиболее распространенных осложнений, связанных с длительным приемом системных ретиноидов, является синдром сухого глаза, ассоциированный с дисфункцией мейбомиевых желез, что требует особого внимания со стороны офтальмологов. Цель: представить клинический случай пациентки, которая проходила курс системной терапии изотретиноином в течение четырех месяцев с целью лечения акне и в результате предъявляла жалобы со стороны органа зрения. Методы. Пациентке была проведена комплексная офтальмологическая диагностика, включающая в себя сбор жалоб и анамнеза, биомикроскопию, а также окрашивание роговицы витальным красителем (флюоресцеином). Дополнительно были использованы следующие методы исследования: оценка неинвазивного времени разрыва слезной пленки, измерение высоты слезного мениска, оценка толщины липидного слоя слезной пленки, мейбография, фотосъемка края века, анализ гиперемии конъюнктивы, а также получение снимка роговицы, окрашенной флюоресцеином. В качестве терапии применяли различные группы препаратов, в том числе увлажняющие капли, репаративные гелевые средства, протекторы роговицы и глюкокортикостероиды. Кроме того, была проведена лечебная манипуляция, заключающаяся в массаже век. Результаты. Спустя три месяца активной терапии удалось достичь положительных результатов, которые проявились в значительном снижении субъективных жалоб со стороны пациента, отсутствии дефектов эпителия роговицы и увеличении времени разрыва слезной пленки. Длительная ремиссия симптомов была зафиксирована через пять месяцев терапии. Заключение. Данное исследование подчеркивает важность междисциплинарного взаимодействия между офтальмологами и дерматологами в процессе ведения пациентов, применяющих длительную системную терапию ретиноидами для лечения акне. Необходима полноценная офтальмологическая диагностика с использованием специализированных методов обследования для детальной оценки клинической картины состояния глаз и своевременного назначения комплексной терапии, что, безусловно, способствует улучшению качества жизни пациентов и предотвращению развития серьезных осложнений.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Acne is a chronic, recurrent, and inflammatory skin disease that that can have significant aesthetic and psychological impacts on patients. The first-line treatment for acne is isotretinoin, which exerts systemic effect, reducing sebum production and alleviating inflammation However, one of the most common complications associated with prolonged systemic retinoid use is dry eye syndrome, linked to meibomian gland dysfunction, warranting special attention from ophthalmologists. Purpose: to present a clinical case of a patient who underwent four months of systemic isotretinoin therapy for acne and subsequently developed ocular complaints. Methods. Comprehensive ophthalmological diagnostics were conducted, including patient history, biomicroscopy, and corneal staining with fluorescein. Additional assessment included non-invasive tear film breakup time, measurement of tear meniscus height, evaluation of the lipid layer thickness of the tear film, meibography, eyelid margin photography, conjunctival hyperemia analysis, and corneal fluorescein staining. Treatment included various groups drug classes such as moisturizing drops, reparative gels, corneal protectors, and glucocorticosteroids. A therapeutic eyelid massage was also performed. Results. After three months of active therapy, the patient exhibited significant improvement, with a marked reduction in subjective complaints, no corneal epithelial defects, and an increase in tear film breakup time. Long-term symptom remission was achieved after five months of therapy. Conclusion. This case highlights the importance of interdisciplinary collaboration between ophthalmologists and dermatologists in managing patients undergoing long-term systemic retinoid therapy for acne. Comprehensive ophthal- mological assessment using specialized diagnostic methods is essential for accurately evaluating the clinical picture of ocular conditions and administering timely, multi-faceted therapy. This approach enhances patients’ quality of life and helps prevent severe complications.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром сухого глаза</kwd><kwd>дисфункция мейбомиевых желез</kwd><kwd>блефарит</kwd><kwd>акне</kwd><kwd>ретиноиды</kwd></kwd-group><kwd-group xml:lang="en"><kwd>dry eye syndrome</kwd><kwd>meibomian gland dysfunction</kwd><kwd>blepharitis</kwd><kwd>acne</kwd><kwd>retinoids</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Матушевская ЕВ, Антонова ЛА, Матушевская ЮИ, Петрова КС. Клинический опыт применения системного изотретиноина в лечении тяжелых форм акне. РМЖ. 2018;8(II):109–112.</mixed-citation><mixed-citation xml:lang="en">Matushevskaya EV, Antonova LA, Matushevskaya YuI, Petrova KS. Clinical experience with systemic isotretinoin in the treatment of severe acne. RMZh. 2018;8(II):109–112. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cunliffe WJ, Van De Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Der matology.1997;194(4):351–357. doi: 10.1159/000246134</mixed-citation><mixed-citation xml:lang="en">Cunliffe WJ, Van De Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Der matology.1997;194(4):351–357. doi: 10.1159/000246134</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Анисимова МЮ. Акне (Acne vulgaris) с позиции доказательной медицины. Вестник репродуктивного здоровья. 2010;3–4:14–23. doi: 10.14341/brh20103-414-23</mixed-citation><mixed-citation xml:lang="en">Anisimova MYu. Acne (Acne vulgaris) from the perspective of evidence-based medicine. Bulletin of Reproductive Health. 2010;3–4:14–23. (In Russ.) doi: 10.14341/brh20103-414-23</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Масюкова СА, Мордовцева ВВ, Кахишвили НН и др. Лечение акне низкими дозами изотретиноина. Клиническая дерматология и венерология. 2013;11(6):7–12.</mixed-citation><mixed-citation xml:lang="en">Masiukova SA, Mordovtseva VV, Kakhishvili NN, et al. Lowdose isotretinoin treatment of acne. Russian Journal of Clinical Dermatology and Venereology. 2013;11(6):7–12. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Львов АН, Корнят МС, Игошина АВ, Назаренко АР. Перспективы в терапии акне: аналитический обзор. Клиническая дерматология и венерология. 2019;18(2):115–128. doi: 10.17116/klinderma201918021115</mixed-citation><mixed-citation xml:lang="en">Lvov AN, Kornyat MS, Igoshina AV, Nazarenko AR. Perspectives in acne therapy: an analytical review. Russian Journal of Clinical Dermatology and Venereology. 2019;18(2):115–128. (In Russ.) doi: 10.17116/klinderma201918021115</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Oon HH, Wong SN, Aw DCW, et al. Acne management guidelines by the dermatological society of singapore. J Clin Aesthet Dermatol. 2019;12(7):34–50.</mixed-citation><mixed-citation xml:lang="en">Oon HH, Wong SN, Aw DCW, et al. Acne management guidelines by the dermatological society of singapore. J Clin Aesthet Dermatol. 2019;12(7):34–50.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fallah H, Rademaker M. Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring. J Dermatolog Treat. 2022;33(5):2414–2424. doi: 10.1080/09546634.2021.1967269</mixed-citation><mixed-citation xml:lang="en">Fallah H, Rademaker M. Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring. J Dermatolog Treat. 2022;33(5):2414–2424. doi: 10.1080/09546634.2021.1967269</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017;30(4). doi: 10.1111/dth.12483</mixed-citation><mixed-citation xml:lang="en">Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017;30(4). doi: 10.1111/dth.12483</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Düzgün E, Özkur E. The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests. J Dermatolog Treat. 2022;33(2):762–768. doi: 10.1080/09546634.2020.1774041</mixed-citation><mixed-citation xml:lang="en">Düzgün E, Özkur E. The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests. J Dermatolog Treat. 2022;33(2):762–768. doi: 10.1080/09546634.2020.1774041</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, et al. Isotretinoin and the eye: A review for the dermatologist. Dermatol Ther. 2020;33(6):e14029. doi: 10.1111/dth.14029</mixed-citation><mixed-citation xml:lang="en">Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, et al. Isotretinoin and the eye: A review for the dermatologist. Dermatol Ther. 2020;33(6):e14029. doi: 10.1111/dth.14029</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Caglar C, Senel E, Sabancilar E, Durmus M. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol. 2017;37(1):197–202. doi: 10.1007/s10792-016-0263-y</mixed-citation><mixed-citation xml:lang="en">Caglar C, Senel E, Sabancilar E, Durmus M. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol. 2017;37(1):197–202. doi: 10.1007/s10792-016-0263-y</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Alfouzan YA, Al-Hammad RA, Alkhuzayem FA, et al. Isotretinoin-related eye dryness in acne patients in Qassim, Saudi Arabia. Cureus. 2023;15(12):e49904. doi: 10.7759/cureus.49904</mixed-citation><mixed-citation xml:lang="en">Alfouzan YA, Al-Hammad RA, Alkhuzayem FA, et al. Isotretinoin-related eye dryness in acne patients in Qassim, Saudi Arabia. Cureus. 2023;15(12):e49904. doi: 10.7759/cureus.49904</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lamberg O, Strome A, Jones F, et al. Ocular side effects of systemic isotretinoin – a systematic review and summary of case reports. Journal of Dermatological Treatment. 2023;34(1):2213364. doi: 10.1080/09546634.2023.2213364</mixed-citation><mixed-citation xml:lang="en">Lamberg O, Strome A, Jones F, et al. Ocular side effects of systemic isotretinoin – a systematic review and summary of case reports. Journal of Dermatological Treatment. 2023;34(1):2213364. doi: 10.1080/09546634.2023.2213364</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Acar Eser N, Kocabeyoğlu S, Atakan N, Irkec M. The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study. Cutan Ocul Toxicol. 2022;41(2):155–161. doi: 10.1080/15569527.2022.2077749</mixed-citation><mixed-citation xml:lang="en">Acar Eser N, Kocabeyoğlu S, Atakan N, Irkec M. The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study. Cutan Ocul Toxicol. 2022;41(2):155–161. doi: 10.1080/15569527.2022.2077749</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zakrzewska A, Wiącek MP, Słuczanowska-Głąbowska S, et al. The effect of oral isotretinoin therapy on meibomian gland characteristics in patients with acne vulgaris. Ophthalmol Ther. 2023;12(4):2187–2197. doi: 10.1007/s40123-023-00737-6</mixed-citation><mixed-citation xml:lang="en">Zakrzewska A, Wiącek MP, Słuczanowska-Głąbowska S, et al. The effect of oral isotretinoin therapy on meibomian gland characteristics in patients with acne vulgaris. Ophthalmol Ther. 2023;12(4):2187–2197. doi: 10.1007/s40123-023-00737-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Moy A, McNamara NA, Lin MC. Effects of isotretinoin on meibomian glands. Optometry and Vision Science. 2015;92(9):925– 930. doi: 10.1097/OPX.0000000000000656</mixed-citation><mixed-citation xml:lang="en">Moy A, McNamara NA, Lin MC. Effects of isotretinoin on meibomian glands. Optometry and Vision Science. 2015;92(9):925– 930. doi: 10.1097/OPX.0000000000000656</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Elubous KA, Toubasi AA, Elubous A, et al. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. Cutan Ocul Toxicol. 2022;41(2):113–122. doi: 10.1080/15569527.2022.2050747</mixed-citation><mixed-citation xml:lang="en">Elubous KA, Toubasi AA, Elubous A, et al. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. Cutan Ocul Toxicol. 2022;41(2):113–122. doi: 10.1080/15569527.2022.2050747</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gurlevik U, Kemeriz F, Yasar E. The effect of isotretinoin on meibomian glands in eyes: a pilot study. Int Ophthalmol. 2022;42(7):2071–2078. doi: 10.1007/s10792-021-02205-1</mixed-citation><mixed-citation xml:lang="en">Gurlevik U, Kemeriz F, Yasar E. The effect of isotretinoin on meibomian glands in eyes: a pilot study. Int Ophthalmol. 2022;42(7):2071–2078. doi: 10.1007/s10792-021-02205-1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Рикс ИА, Труфанов СВ, Бутаба Р. Современные подходы к лечению дисфункции мейбомиевых желез. Вестник офтальмологии. 2021;137(1):130136. doi: 10.17116/oftalma2021137011130</mixed-citation><mixed-citation xml:lang="en">Riks IA, Trufanov SV, Boutaba R. Modern approaches to the treatment of meibomian gland dysfunction. Russian Annals of Ophthalmology. 2021;137(1):130136. (In Russ.) doi: 10.17116/oftalma2021137011130</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Медведев ИБ, Трубилин ВН, Полунина ЕГ и др. Современные возможности физиотерапевтического лечения дисфункции мейбомиевых желез. Офтальмология. 2022;19(2):235–241. doi: 10.18008/1816-5095-2022-2-235-241</mixed-citation><mixed-citation xml:lang="en">Medvedev IB, Trubilin VN, Poluninа EG, et al. Modern possibilities of physiotherapeutic treatment for meibomian gland dysfunction. Ophthalmology in Russia. 2022;19(2):235–241. (In Russ.) doi: 10.18008/1816-5095-2022-2-235-241</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Трубилин ВН, Полунина ЕГ, Маркова ЕЮ и др. Терапевтическая гигиена век в алгоритмах профилактики и лечения заболеваний глазной поверхности. Ч. 1. Офтальмология. 2016;13(2):122–127. doi: 10.18008/1816-5095-2016-2-122-127</mixed-citation><mixed-citation xml:lang="en">Trubilin VN, Poluninа EG, Kurenkov VV, et al. Therapeutic eyelid hygiene in the algorithms for prevention and treatment of ocular surface diseases. Ophthalmology in Russia. 2016;13(2):122–127. (In Russ.) doi: 10.18008/1816-5095-2016-2-122-127</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bilgic AA, Sabur H, Acar M, Canpolat F. Effects of li pidcontaining eye drops on the ocular surface and in vivo confocal microscopy findings in patients using syste mic isotretinoin. Cutan Ocul Toxicol. 2023;42(1):25–31. doi: 10.1080/15569527.2023.2166523</mixed-citation><mixed-citation xml:lang="en">Bilgic AA, Sabur H, Acar M, Canpolat F. Effects of li pidcontaining eye drops on the ocular surface and in vivo confocal microscopy findings in patients using syste mic isotretinoin. Cutan Ocul Toxicol. 2023;42(1):25–31. doi: 10.1080/15569527.2023.2166523</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Acet Y, Bilik L. Instability of tear film and loss of meibomian glands in patients with acne vulgaris. Arq Bras Oftalmol. 2022;87(2):0038. doi: 10.5935/0004-2749.2021-0038</mixed-citation><mixed-citation xml:lang="en">Acet Y, Bilik L. Instability of tear film and loss of meibomian glands in patients with acne vulgaris. Arq Bras Oftalmol. 2022;87(2):0038. doi: 10.5935/0004-2749.2021-0038</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Майчук ДЮ, Лошкарева АО, Цветкова ТВ. Алгоритм комплексной терапии синдрома сухого глаза с дисфункцией мейбомиевых желез интенсивным импульсным светом (IPL) в сочетании с гигиеной век и слезозамещением. Офтальмология. 2020;17(3s):640–647. doi: 10.18008/1816-5095-2020-3S-640-647</mixed-citation><mixed-citation xml:lang="en">Maуchuk DYu, Loshkareva AO, Tsvetkova TV. Complex treatment algorithm for dry eye syndrome with meibomian gland dysfunction: combination of intense pulsed light (IPL) with eyelid hygiene and artificial tears. Ophthalmology in Russia. 2020;17(3s):640–647. (In Russ.) doi: 10.18008/1816-5095-2020-3S-640-647</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Toyos R, Toyos M, Willcox J, et al. Evaluation of the safety and efficacy of intense pulsed light treatment with meibomian gland expression of the upper eyelids for dry eye disease. Photobiomodul Photomed Laser Surg. 2019;37(9):527–531. doi: 10.1089/photob.2018.4599</mixed-citation><mixed-citation xml:lang="en">Toyos R, Toyos M, Willcox J, et al. Evaluation of the safety and efficacy of intense pulsed light treatment with meibomian gland expression of the upper eyelids for dry eye disease. Photobiomodul Photomed Laser Surg. 2019;37(9):527–531. doi: 10.1089/photob.2018.4599</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90. doi: 10.1016/j.ajo.2017.08.021</mixed-citation><mixed-citation xml:lang="en">Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90. doi: 10.1016/j.ajo.2017.08.021</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Wang J, Gao Y. Eyelid cleaning: Methods, tools, and clinical applications. Indian J Ophthalmol. 2023;71(12):3607– 3614. doi: 10.4103/IJO.IJO_1457_23</mixed-citation><mixed-citation xml:lang="en">Zhang L, Wang J, Gao Y. Eyelid cleaning: Methods, tools, and clinical applications. Indian J Ophthalmol. 2023;71(12):3607– 3614. doi: 10.4103/IJO.IJO_1457_23</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zainab Z, Malik NA, Obaid S, et al. Effectiveness of oral Omega 3 in reducing mucocutaneous side effects of oral isotretinoin in patients with acne vulgaris. J Ayub Med Coll Abbottabad. 2021;33(1):60–63.</mixed-citation><mixed-citation xml:lang="en">Zainab Z, Malik NA, Obaid S, et al. Effectiveness of oral Omega 3 in reducing mucocutaneous side effects of oral isotretinoin in patients with acne vulgaris. J Ayub Med Coll Abbottabad. 2021;33(1):60–63.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
